Prevention and Reversal of Frailty in Heart Failure
被引:12
|
作者:
Aili, Samira R.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Notre Dame, Fac Med, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Aili, Samira R.
[1
]
Lo, Phillip
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia
Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
Univ New South Wales, Fac Med, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Lo, Phillip
[2
,3
,4
]
Villanueva, Jeanette E.
论文数: 0引用数: 0
h-index: 0
机构:
Victor Chang Cardiac Res Inst, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Villanueva, Jeanette E.
[3
]
Joshi, Yashutosh
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia
Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
Univ New South Wales, Fac Med, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Joshi, Yashutosh
[2
,3
,4
]
Emmanuel, Sam
论文数: 0引用数: 0
h-index: 0
机构:
Univ Notre Dame, Fac Med, Sydney, NSW, Australia
St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia
Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
Univ New South Wales, Fac Med, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Emmanuel, Sam
[1
,2
,3
,4
]
Macdonald, Peter S.
论文数: 0引用数: 0
h-index: 0
机构:
St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia
Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
Univ New South Wales, Fac Med, Sydney, NSW, AustraliaUniv Notre Dame, Fac Med, Sydney, NSW, Australia
Macdonald, Peter S.
[2
,3
,4
]
机构:
[1] Univ Notre Dame, Fac Med, Sydney, NSW, Australia
[2] St Vincents Hosp, Heart Transplant Unit, Sydney, NSW, Australia
[3] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia
[4] Univ New South Wales, Fac Med, Sydney, NSW, Australia
Background: Frailty is prevalent in patients with heart failure (HF) and associated with increased morbidity and mortality. Hence, there has been increased interest in the reversibility of frailty following treatment with medication or surgery. This systematic review aimed to assess the reversibility of frailty in patients with HF before and after surgical interventions aimed at treating the underlying cause of HF. It also aimed to assess the efficacy of cardiac rehabilitation and prehabilitation in reversing or preventing frailty in Methods and Results: Searches of PubMed, MEDLINE and Academic Search Ultimate identified studies with HF patients undergoing interventions to reverse frailty. Titles, abstracts and full texts were screened for eligibility based on the PRISMA guidelines and using predefined inclusion/exclusion criteria in relation to participants, intervention, control, outcome and study design. In total, 14 studies were included: 3 assessed the effect of surgery, 7 assessed the effect of rehabilitation programs, 2 assessed the effect of a prehabilitation program and 2 assessed the effect of program interruptions on HF patients. Conclusions: Overall, it was found that frailty is at least partially reversible and potentially preventable in patients with HF. Interruption of rehabilitation programs resulted in deterioration of the frailty status. Future research should focus on the role of prehabilitation in mitigating frailty prior to surgical intervention.
机构:
Case Western Reserve Univ, Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USACase Western Reserve Univ, Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA
Boxer, Rebecca S.
Shah, Khanjan B.
论文数: 0引用数: 0
h-index: 0
机构:
Case Western Reserve Univ, Cleveland, OH 44106 USACase Western Reserve Univ, Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA
Shah, Khanjan B.
Kenny, Anne M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Connecticut, Ctr Aging, Farmington, CT USACase Western Reserve Univ, Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA
机构:
Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Los Angeles, CA 90095-1679, 47-123 CHSAhmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Los Angeles, CA 90095-1679, 47-123 CHS
Horwich T.B.
Fonarow G.C.
论文数: 0引用数: 0
h-index: 0
机构:
Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Los Angeles, CA 90095-1679, 47-123 CHSAhmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Los Angeles, CA 90095-1679, 47-123 CHS